Zonisamide sodium

For research use only. Not for therapeutic Use.

  • CAT Number: I004568
  • CAS Number: 68291-98-5
  • Molecular Formula: C8H7N2NaO3S
  • Molecular Weight: 234.21
  • Purity: ≥95%
Inquiry Now

Zonisamide sodium(Cat No.:I004568)is a sodium salt form of zonisamide, a sulfonamide-based anticonvulsant used primarily in the management of epilepsy. It works by stabilizing neuronal membranes, reducing repetitive neuronal firing through inhibition of sodium and calcium channels, and modulating GABA-mediated neurotransmission. Zonisamide sodium has shown efficacy in treating partial-onset seizures and is being explored for neuroprotective potential in neurodegenerative conditions like Parkinson’s disease. Its multi-targeted action makes it a valuable tool in neurological research, particularly in studies focused on seizure control and neuroprotection strategies.


Catalog Number I004568
CAS Number 68291-98-5
Synonyms

sodium;1,2-benzoxazol-3-ylmethylsulfonylazanide

Molecular Formula C8H7N2NaO3S
Purity ≥95%
Target Calcium Channel
Solubility DMSO 42 mg/mL; Water <1 mg/mL
Storage Store at -20C
IUPAC Name sodium;1,2-benzoxazol-3-ylmethylsulfonylazanide
InChI InChI=1S/C8H7N2O3S.Na/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7;/h1-4H,5H2,(H-,9,11,12);/q-1;+1
InChIKey ZVBIRPKGWOVBLG-UHFFFAOYSA-N
SMILES C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)[NH-].[Na+]
Reference

<p style=/line-height:25px/>
<br>[1]. Peters DH, et al. Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy. Drugs. 1993 May;45(5):760-87.
<br>[2]. Brodie MJ, et al. Zonisamide as adjunctive therapy for refractory partial seizures. Epilepsy Res. 2006 Feb;68 Suppl 2:S11-6. Epub 2005 Nov 28.
</p>

Request a Quote